ClinicalTrials.govpublic full text
S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer
recurrent non-small cell lung carcinoma, stage iv non-small cell lung cancer, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830205
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.